Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1.42 Cr₹-4.58 Cr₹0.53 Cr₹2.91 Cr₹0.22 Cr

What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?

The latest Cash Flow from Operating Activities ratio of INDO US BIOTECH is ₹1.42 Cr based on Mar2025 Standalone results.
Year Cash Flow from Operating Activities
Mar2025₹1.42 Cr
Mar2024₹-4.58 Cr
Mar2023₹0.53 Cr
Mar2022₹2.91 Cr
Mar2021₹0.22 Cr

How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹1.42 Cr
Positive
Mar2024 ₹-4.58 Cr
Negative
Mar2023 ₹0.53 Cr
-81.91
Mar2022 ₹2.91 Cr
1,192.44
Mar2021 ₹0.22 Cr -

Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹203.9 Cr 5.2% -30% -38.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹9,734.2 Cr 0.4% -17.4% -7.8% Stock Analytics
KAVERI SEED COMPANY ₹4,037.7 Cr 0.2% -3.8% -31.7% Stock Analytics
VENKYS (INDIA) ₹1,720.2 Cr 7% -8.4% -19.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹802.7 Cr -3.9% -15.5% -36.1% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹388.6 Cr 4.9% -13.1% -29.3% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

5.2%

-30%

-38.5%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses